Assessment of the relation between biomarkers for smoking and biomarkers for acrylamide exposure in humans

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 11, 2007, Pages 2471-2478

  Vesper, Hubert W ^a   Bernert, John T ^a   Ospina, Maria ^a   Meyers, Tunde ^a   Ingham, Leigha ^a   Smith, Antoinette ^a   Myers, Gary L ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; BIOLOGICAL MARKER; GLYCIDAMIDE; HEMOGLOBIN; TOBACCO SMOKE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); EXPOSURE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION;

ACRYLAMIDE; ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; COTININE; EPOXY COMPOUNDS; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NICOTINE; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 38849173632     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-1058     Document Type: Article

References (44)

1. International Agency for Research on Cancer (IARC). Acrylamide. IARC Monogr Eval Carcinog Risks Hum 1995;60:1-45.
2. Calleman CJ, Wu Y, He F, et al. Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol Appl Pharmacol 1994;126:361-71.
3. LoPachin RM, Balaban CD, Ross JF. Acrylamide axonopathy revisited. Toxicol Appl Pharmacol 2003;188:135-53.
4. Miller MS, Spencer PS. The mechanisms of acrylamide axonopathy. Annu Rev Pharmacol Toxicol 1985;25:643-66.
5. Bergmark E, Calleman CJ, Costa LG. Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol Appl Pharmacol 1991;111:352-63.
6. Hagmar L, Törnqvist M, Nordander C, et al. Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. Scand J Work Environ Health 2001;27:219-26.
7. Sumner SC, MacNeela JP, Fennell TR. Characterization and quantitation of urinary metabolites of [1,2,3-13C]acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy. Chem Res Toxicol 1992;5:81-9.
8. Marsh GM, Lucas LJ, Youk AO, Schall LC. Mortality patterns among workers exposed to acrylamide: 1994 follow up. Occup Environ Med 1991;56:181-190.
9. Smith JC, Perfetty TA, Rumple MA, Rodgam A, Doolittle DJ. IARC group 2A carcinogens. Food Chem Toxicol 2000;38:371-8.
10. Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 2002;50:4998-5006.
11. Mottram DS, Wedzicha BL, Dodson AT. Acrylamide is formed in the Maillard reaction. Nature 2002;419:448-9.
12. Stadler RH, Blank I, Varga N, et al. Acrylamide from Maillard reaction products. Nature 2002;419:449-50.
13. Friedman M. Chemistry, biochemistry, and safety of acrylamide. J Agric Food Chem 2003;51:4504-26.
14. Dybing E, Farmer PB, Andersen M, et al. Human exposure and internal dose assessments of acrylamide in food. Food Chem Toxicol 2005;43:365-410.
15. Sharp D. Acrylamide in food. Lancet 2003;361:361-2.
16. Bergmark E, Calleman CJ, He F, Costa LG. Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. Toxicol Appl Pharmacol 1993;120:45-54.
17. Fennell TR, Snyder RW, Krol WL, Sumner SC. Comparison of the hemoglobin adducts formed by administration of N-methylolacrylamide and acrylamide to rats. Toxicol Sci 2003;71:164-75.
18. Perez HL, Cheong HK, Yang JS, Osterman-Golkar S. Simultaneous analysis of hemoglobin adducts of acrylamide and glycidamide by gas chromatography-mass spectrometry. Anal Biochem 1999;274:59-68.
19. Schettgen T, Broding HC, Angerer J, Drexler H. Hemoglobin adducts of ethylene oxide, propylene oxide, acrylonitrile and acrylamide-biomarkers in occupational and environmental medicine. Toxicol Lett 2002;134:65-70.
20. Törnqvist M, Ehrenberg L. Estimation of cancer risk caused by environmental chemicals based on in vivo dose measurement. J Environ Pathol Toxicol Oncol 2001;20:263-71.
21. Hagmar L, Wirfält E, Paulsson B, Törnqvist M. Differences in hemoglobin adduct levels of acrylamide in the general population with respect to dietary intake, smoking habits and gender. Mutat Res 2005;580:157-65.
22. Schettgen T, Weiss T, Drexler H, Angerer J. A first approach to estimate the internal exposure to acrylamide in smoking and non-smoking adults from Germany. Int J Hyg Environ Health 2003;206:9-14.
23. Schettgen T, Rossbach B, Kutting B, Letzel S, Drexler H, Angerer J. Determination of haemoglobin adducts of acrylamide and glycidamide in smoking and non-smoking persons of the general population. Int J Hyg Environ Health 2004;207:531-9.
24. Benowitz NL, Hall SM, Herning RI, Jacob P III, Jones RT, Osman AL. Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med 1983;309:139-42.
25. Scherer G. Smoking behavior and compensation: a review of the literature. Psychopharmacology (Berl) 1999;45:1-20.
26. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996;18:188-204.
27. Perez-Stable EJ, Benowitz NL, Marin G. Is serum cotinine a better measure of cigarette smoking than self-report? Prev Med 1995;24:171-9.
28. Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect 1999;107:349-55.
29. Vesper HW, Ospina M, Meyers T, et al. Automated method for measuring globin adducts of acrylamide and glycidamide at optimized Edman reaction conditions. Rapid Commun Mass Spectrom 2006;20:959-64.
30. Bernert JT, Jr., Turner WE, Pirkle JL, et al. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clin Chem 1997;43:2281-91.
31. Bernert JT, Jr., McGuffey JE, Morrison MA, Pirkle JL. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography-tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. J Anal Toxicol 2000;24:333-9.
32. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 1996;275:1233-40.
33. Benowitz NL, Jacob P III. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 1994;56:483-93.
34. Törnqvist M, Fred C, Haglund J, Helleberg H, Paulsson B, Rydberg P. Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications. J Chromatogr B Analyt Technol Biomed Life Sci 2002;778:279-308.
35. Osterman-Golkar S, Vesper HW. Assessment of the relationship between glucose and A1c using kinetic modeling. J Diabetes Complications 2006;20:285-94.
36. Doerge DR, Young JF, McDaniel LP, Twaddle NC, Churchwell MI. Toxicokinetics of acrylamide and glycidamide in Fischer 344 rats. Toxicol Appl Pharmacol 2005;208:199-209.
37. Calleman CJ, Bergmark E, Costa LG. Acrylamide is metabolized to glycidamide in the rat: evidence from hemoglobin adduct formation. Chem Res Toxicol 1990;3:406-12.
38. Glatt H, Schneider H, Liu Y. V79-2E1-1A1, a cell line for the sensitive detection of genotoxic effects induced by carbohydrate pyrolysis products and other food-borne chemicals. Mutat Res 2005;580:41-52.
39. Sumner SC, Fennell TR, Moore TA, Chanas B, Gonzalez F, Ghanayem BI. Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem Res Toxicol 1999;12:1110-6.
40. Agundez JA. Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 2004;5:211-24.
41. Fustinoni S, Soleo L, Warholm M, et al. A. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidemiol Biomarkers Prev 2002;11:1082-90.
42. Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10:1239-48.
43. Kessova I, Cederbaum AI. CYP2E1: biochemistry, toxicology, regulation and function in ethanol-induced liver injury. Curr Mol Med 2003;3:509-18.
44. Schoedel KA, Tyndale RF. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications. Biochim Biophys Acta 2003;1619:283-90.